Regulations.gov document
Guidance for Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for…
Other · FDA-2013-D-0589 · posted Nov 3, 2015
Key facts
| Document ID | FDA-2013-D-0589-0012 |
|---|---|
| Title | Guidance for Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2013-D-0589 |
| Posted | Nov 3, 2015 |
| Comment period opens | Nov 3, 2015 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: